Penumbra (PEN) Cash from Investing Activities (2014 - 2026)

Penumbra (PEN) reported Cash from Investing Activities of -$30.6 million for Q1 2026, down 6002.19% year-over-year from $519010.6 in Q1 2025, and up 86.42% quarter-over-quarter from -$225.6 million in Q4 2025.

Penumbra (PEN) Cash from Investing Activities (2014 - 2026) Analysis & Trends

Penumbra (PEN) has 13 years of Cash from Investing Activities data on file, last reported at -$30.6 million in Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at -$30.6 million, down 6002.19% year-over-year; the trailing twelve-month figure through Mar 2026 was -$434.7 million (down 840.1% YoY), and the FY2025 annual result was -$404.6 million, down 621.22% from the prior year.
  • Cash from Investing Activities climbed to -$30.6 million in Q1 2026 per PEN's latest filing, from -$225.6 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $35.7 million in Q3 2024 and troughed at -$225.6 million in Q4 2025.
  • A 5-year average of -$18.8 million and a median of $8.6 million in 2022 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2022 and 2026: Cash from Investing Activities surged 744.73% in 2022, then tumbled 6002.19% in 2026.
  • A 5-year view of Cash from Investing Activities shows it stood at $8.6 million in 2022, then soared by 181.25% to $24.3 million in 2023, then slumped by 145.12% to -$11.0 million in 2024, then sank by 1959.76% to -$225.6 million in 2025, then surged by 86.42% to -$30.6 million in 2026.
  • Business Quant data shows PEN's Cash from Investing Activities at -$30.6 million in Q1 2026, -$225.6 million in Q4 2025, and -$162.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -20.32 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn -185.00 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn -816.00 Mn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -92.80 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -2.50 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -475.32 Mn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -298.50 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -217.20 Mn
10 Penumbra 12.51 Bn 11.90 Bn 253.41 Mn -30.63 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -30.63 Mn
Mar 31, 2026 -30.63 Mn
Dec 31, 2025 -225.65 Mn
Dec 31, 2025 -225.65 Mn
Sep 30, 2025 -162.86 Mn
Sep 30, 2025 -162.86 Mn
Jun 30, 2025 -15.58 Mn
Jun 30, 2025 -15.58 Mn
Mar 31, 2025 -502,000.00
Mar 31, 2025 -502,000.00
Dec 31, 2024 -10.96 Mn
Dec 31, 2024 -10.96 Mn
Sep 30, 2024 35.72 Mn
Sep 30, 2024 35.72 Mn
Jun 30, 2024 34.47 Mn
Jun 30, 2024 34.47 Mn
Mar 31, 2024 18.38 Mn
Mar 31, 2024 18.38 Mn
Dec 31, 2023 24.28 Mn
Dec 31, 2023 24.28 Mn